Prostate Cancer Bone Metastases Blocked with HIV Drug in Mice

Prostate Cancer Bone Metastases Blocked with HIV Drug in Mice
Lethal bone metastases derived from prostate cancer may be readily prevented with a drug approved to treat HIV, according to new research from the laboratory of Richard Pestell, MD, PhD, MBA, at Thomas Jefferson University. The team found prostate cancer and HIV share a common receptor known as CCR5 and that blocking CCR5 reduces prostate

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , , .

Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.

Leave a Comment

Your email address will not be published. Required fields are marked *